Please login to the form below

Not currently logged in
Email:
Password:

Gyroscope

This page shows the latest Gyroscope news and features for those working in and with pharma, biotech and healthcare.

Life sciences and NHS feature in Johnson speech – but Brexit promises predominate

Life sciences and NHS feature in Johnson speech – but Brexit promises predominate

This was an apparent reference to Gyroscope, the company based in the Stevenage biotech cluster near London, which is testing its gene therapy for advanced dry Age-related Macular Degeneration (AMD).

Latest news

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Gyroscope Therapeutics appoints CEO Gyroscope Therapeutics appoints CEO

    Dr Soraya Bekkali joins from biotech firm Lysogene. Ophthalmology group Gyroscope Therapeutics has appointed Dr Soraya Bekkali as its chief executive officer and director of its board. ... Gyroscope has a unique translational approach to tackling complex

  • Anne Prener to lead Freeline Therapeutics Anne Prener to lead Freeline Therapeutics

    She joins from Gyroscope Therapeutics to take up CEO role. London, UK-based gene therapy-focused biopharmaceutical company Freeline Therapeutics has appointed Anne Prener as its new chief executive officer. ... Prior to Gyroscope, Frener served as vice

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics